We are live on ! Find out more
TARO

Taro Pharmaceutical Industries Ltd.
TARO

Delisted

TARO was delisted on the 21st of June, 2024.

Back to rankings

159 hedge funds and large institutions have $1.02B invested in Taro Pharmaceutical Industries Ltd. in 2016 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 84 increasing their positions, 33 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

485% more call options, than puts

Call options by funds: $6.99M | Put options by funds: $1.19M

155% more repeat investments, than reductions

Existing positions increased: 84 | Existing positions reduced: 33

24% more capital invested

Capital invested by funds: $826M → $1.02B (+$199M)

5% less funds holding

Funds holding: 167 → 159 (-8)

16% less first-time investments, than exits

New positions opened: 26 | Existing positions closed: 31

38% less funds holding in top 10

Funds holding in top 10: 8 → 5 (-3)

Holders
159
Holders Change
-8
Holders Change %
-4.79%
% of All Funds
4.24%
Holding in Top 10
5
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-37.5%
% of All Funds
0.13%
New
26
Increased
84
Reduced
33
Closed
31
Calls
$6.99M
Puts
$1.19M
Net Calls
+$5.79M
Net Calls Change
+$6.04M

Top Buyers

1
Goldman Sachs
Goldman Sachs
New York
+$40.6M
2
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
+$20.1M
3
Renaissance Technologies
Renaissance Technologies
New York
+$18.4M
4
BIT
BlackRock Institutional Trust
California
+$15.2M
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$14.9M

Top Sellers

1
GCM
Greywolf Capital Management
New York
-$35.1M
2
AllianceBernstein
AllianceBernstein
Tennessee
-$8.62M
3
GPC
Guardian Point Capital
Virginia
-$7.16M
4
Morgan Stanley
Morgan Stanley
New York
-$5.21M
5
AL
AJO LP
Pennsylvania
-$4.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
AIG
126
American International Group
New York
$205K +$132K +932 +197%
LIA
127
LS Investment Advisors
Michigan
$203K – – –
Victory Capital Management
128
Victory Capital Management
Texas
$175K +$99.4K +701 +140%
AIM
129
Acrospire Investment Management
Illinois
$87K -$14.2K -100 -14%
AG
130
Advisor Group
Arizona
$79K +$79K +557 New
PMAM
131
Picton Mahoney Asset Management
Ontario, Canada
$73K – – –
Daiwa Securities Group
132
Daiwa Securities Group
Japan
$44K +$42.5K +300 New
CG
133
Cutler Group
California
$43K -$99.3K -700 -70%
TRCT
134
Tower Research Capital (TRC)
New York
$41K +$19.4K +137 +94%
RFA
135
Reilly Financial Advisors
California
$38K – – –
WBC
136
Westpac Banking Corp
Australia
$37.4K +$26.8K +189 +278%
LTFS
137
Ladenburg Thalmann Financial Services
Florida
$37K -$26.9K -190 -43%
DVM
138
Dreman Value Management
Florida
$37K +$12.1K +85 +49%
PNC Financial Services Group
139
PNC Financial Services Group
Pennsylvania
$30K -$70.9K -500 -71%
CBOA
140
Commonwealth Bank of Australia
Australia
$29K +$14.2K +100 +100%
Federated Hermes
141
Federated Hermes
Pennsylvania
$28K +$27.7K +195 New
CCA
142
Checchi Capital Advisers
California
$24K +$1.99K +14 +9%
WEC
143
Winslow Evans & Crocker
Massachusetts
$19.4K +$142 +1 +0.8%
MAM
144
Mizuho Asset Management
Japan
$17K +$16.7K +118 New
MFS
145
MSI Financial Services
Massachusetts
$16K -$21.4K -151 -58%
Carson Wealth (CWM LLC)
146
Carson Wealth (CWM LLC)
Nebraska
$16K – – –
NIPH
147
NN Investment Partners Holdings
Netherlands
$15K – – –
VIA
148
Vantage Investment Advisors
Pennsylvania
$15K +$14.2K +100 New
HIM
149
Hillsdale Investment Management
Ontario, Canada
$9K -$28.4K -200 -77%
DADC
150
D.A. Davidson & Co
Montana
$9K -$2.13K -15 -19%
4 5
6
7 8

TARO Hedge Fund Activity: Q2 2016 in Review

159 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Taro Pharmaceutical Industries Ltd. (TARO) for Q2 2016, worth a combined $1.02B — up 24% from $826M a quarter earlier.

Sellers outnumbered buyers: 31 funds closed out of TARO and 26 opened new positions — a net loss of 5 holders — while 33 trimmed existing stakes and 84 added.

The largest buyer was Goldman Sachs, adding an estimated $40.6M. The largest seller was Greywolf Capital Management, exiting entirely with an estimated $35.1M sold.

  • 159 institutional investors held Taro Pharmaceutical Industries Ltd. (TARO) as of Q2 2016, down from 167 in Q1 2016.
  • Funds reported $1.02B of Taro Pharmaceutical Industries Ltd. stock for Q2 2016, up 24% quarter-over-quarter.
  • 26 funds opened new Taro Pharmaceutical Industries Ltd. positions in Q2 2016 and 31 closed out, a net change of -5 holders.
  • The largest Taro Pharmaceutical Industries Ltd. buyer in Q2 2016 was Goldman Sachs, an estimated $40.6M added.
  • The largest Taro Pharmaceutical Industries Ltd. seller in Q2 2016 was Greywolf Capital Management, an estimated $35.1M sold.

Based on aggregated 13F filings for Q2 2016.